Microglia and astrocytes have been considered until now as cells with very distinct identities. Here, we assessed the heterogeneity within microglia/monocyte cell population in mouse hippocampus and determined their response to injury, by using single-cell gene expression profiling of cells isolated from uninjured and deafferented hippocampus. We found that in individual cells, microglial markers Cx3cr1, Aif1, Itgam, and Cd68 were co-expressed. Interestingly, injury led to the co-expression of the astrocyte marker Gfap in a subpopulation of Cx3cr1-expressing cells from both the injured and contralesional hippocampus. Cells co-expressing astrocyte and microglia markers were also detected in the in vitro LPS activation/injury model and in sections from human brain affected by stroke, Alzheimer's disease, and Lewy body dementia. Our findings indicate that injury and chronic neurodegeneration lead to the appearance of cells that share molecular characteristics of both microglia and astrocytes, 2 cell types with distinct embryologic origin and function.
Introduction
Astrocytes and microglia are the principal defensive cell types in the central nervous system (CNS) (Kettenmann et al. 2011; Pekny and Pekna 2014; Pekny et al. 2016) . Microglia are derived from the embryonic precursors that enter the CNS early in development (Ginhoux and Jung 2014) and integrate into neural networks contributing to synaptic remodeling and plasticity, regulation of brain homeostasis, and physiological phagocytosis of redundant (apoptotic) neurons, thus protecting the structural and functional integrity of the nervous tissue (Kettenmann et al. 2011) . Although the notion of morphological and functional heterogeneity of microglia is universally accepted, it remains unknown whether different phenotypes of microglia reflect the distinct microglia subpopulations or result from responses of a homogenous cell population to a specific stimulation. Experimental evidence indicates region-specific differences in microglia density, phenotype and responsiveness (de Haas et al. 2008; Doorn et al. 2015; Grabert et al. 2016) , and yet the knowledge about functional diversity of microglia residing within the same brain region and the corresponding molecular basis thereof is limited.
Several research groups have assessed the microglia transcriptome under normal and disease conditions (Orre et al. 2014; Zhang et al. 2014; Bennett et al. 2016; Grabert et al. 2016) , for review see Wes et al. (2016) , albeit these studies only provide information about the average transcriptome of highly enriched microglia or microglia/macrophage populations. If genes are expressed by only a small subpopulation, their expression and alterations in disease conditions might go unnoticed against the background of the total cell population. By assessing gene expression levels in individual cells that are profiled one by one, it is possible to assess the cell heterogeneity and in much greater detail study the response to a challenge (Stahlberg and Kubista 2014) .
The molecular signature of microglia bears the characteristics of myeloid lineage. The macrophage-specific allograft inflammatory factor 1 (AIF1, also known as ionized calcium-binding adaptor molecule 1 (Iba1)), the integrin CD11b and CD68 are regarded as reliable markers of microglia (de Haas et al. 2008 ) and macrophages (Arnaout 1990; Holness and Simmons 1993; Imai et al. 1996) . The complement component C1q is highly expressed in microglia and the number of cells expressing this gene is increased after injury (Schafer et al. 2000; Lynch et al. 2004; Depboylu et al. 2011a Depboylu et al. , 2011b . The chemokine receptor CX3CR1 is selectively expressed by resident microglia (Gautier et al. 2012 , Wolf et al. 2013 ) and infiltrating monocytes (Saederup et al. 2010; Mizutani et al. 2012) . CC chemokine receptor 2 (CCR2) plays a critical role in the brain infiltration of monocytes, with microglia and astrocytes being the major sources of CCR2 ligand MCP-1/ CCL2 within the lesion-reactive hippocampus (Babcock et al. 2003; Mildner et al. 2007) .
Astrocytes, the main housekeeping cells of the CNS, perform multiple homeostatic functions, including recycling of neurotransmitters, control over ion homeostasis, and providing neurons with energy substrates. Astrocytes are also important regulators of neuronal functions and control the generation of new nerve cells and structural as well as functional synapse remodeling (reviewed in Pekny and Pekna 2014) . Glial fibrillary acidic protein (GFAP) is the principal intermediate filament (nanofilament) protein in mature astrocytes and is routinely used as an astrocyte marker (Eng et al. 2000; Hol and Pekny 2015) . The functions of GFAP range from modulation of cell motility of astrocytes to determining their functional state and intracellular signaling (Pekny and Pekna 2004) . Under basal conditions, glutamate transporters EAAT-1/GLAST and EAAT-2/GLT-1 are expressed predominantly by astrocytes (Sheldon and Robinson 2007) , although some degree of expression of these markers has been reported in cultured microglia (Morioka et al. 2008) . Glutamine synthetase plays a key role in the detoxification of brain ammonia and metabolic regulation of glutamate. It has been considered a marker enzyme for astrocytes, although its expression has been described also in oligodendrocytes (Miyake and Kitamura 1992) . In the brain, the intermediate filament protein vimentin is expressed in astrocytes and endothelial cells; also, vimentin in microglia was proposed to be involved in controlling microglia activation (Jiang et al. 2012) .
We performed single-cell gene expression profiling of freshly isolated cells from uninjured mouse hippocampus and hippocampus after partial deafferentation to assess the heterogeneity of hippocampal microglia and determine their response to injury. To allow examination of potential overlap in gene expression by an unbiased approach, cells isolated from the dissociated tissue were assessed on a single-cell level without any prior selection. We found that in the uninjured hippocampus, Cx3cr1 and the astrocyte marker Gfap were expressed in 2 non-overlapping populations of cells. Injury led to the coexpression of these markers in a subpopulation of cells isolated from the mouse brain. CX3CR1 and GFAP were also coexpressed in cultured cells exposed to LPS in vitro. Cells coexpressing astrocyte and microglia markers were present in sections from human brain affected by Alzheimer's disease (AD), Lewy body dementia, and stroke. These findings provide the evidence that in the mouse as well as in the human brain, injury leads to the appearance of cells that share molecular signature of microglia and astrocytes.
Material and Methods

Mice
Three-month-old C57Bl/6 male mice were used for single-cell gene expression analysis. For quantification of AIF1 immunoreactive cells, 3-month-old C57Bl/6 males expressing enhanced green fluorescent protein (GFP) under the control of the endogenous Cx3cr1 locus (heterozygote for Cx3cr1 tm1Litt , The Jackson laboratory, Bar Harbor, ME, USA) were used. The same mouse strain was also used for preparation of microglia and astrocyte primary cultures. The mice were housed in a barrier animal facility with a 12-h light/dark cycle and fed ad libitum. All experiments were conducted according to protocols approved by the Ethics Committee of the University of Gothenburg (ethical permission nr 57-2009 and 40-2012) .
Surgical Procedures
Unilateral entorhinal cortex lesion was performed as described (Wilhelmsson et al. 2006; . Anesthetized mice were placed in a stereotactic frame, and a hole was drilled through the skull. A retractable wire knife (David Kopf Instruments, Tujunga, CA) was lowered 1 mm from the dura 3.6 mm laterally and −0.1 mm posterior to lambda. The knife was extended 2 mm horizontally and then lowered 2 mm twice, once at 30°a nd once at −135°to avoid the hippocampal formation. The mice were kept in heated cages until they recovered from anesthesia.
Single-Cell Isolation and cDNA Synthesis
Four days after injury, hippocampi were removed and dissociated with a Neural Tissue Dissociation Kit (P) (Miltenyi Biotec, Bergisch Gladbach, Germany). Myelin debris was removed with Myelin Removal Beads I (Miltenyi Biotec) and a MACS Separator (Miltenyi Biotec). Without any additional sorting or enrichment of any particular cell population, single cells were sorted by flow cytometry with a BD FACSAria (Becton Dickinson) into 96-well plates containing 5 µl of mQ water with 1 µg/µl bovine serum albumin (Thermo Scientific, Lithuania) per well as described (Stahlberg et al. 2009 ). Samples were frozen at −80°C until analysis. Due to their elaborate dendritic morphology, hippocampal neurons are highly vulnerable to even gentle tissue dissociation, which conceivably led to depletion of neuronal cells in the single-cell preparations in our study. SuperScript III Reverse Transcriptase (Life Technologies, Carlsbad, CA, USA) was used for reverse transcription (RT). Lysed single cells in 6.5 µl of water containing 0.5 mM dNTP (Sigma-Aldrich, St. Louis, MO, USA), 2.5 µM oligo(dT 15 ) (Eurofins MWG Operon, Ebersberg, Germany), and 2.5 µM random hexamers (Eurofins MWG) (all final concentrations) were incubated at 65°C for 5 min; 50 mM Tris-HCl, 75 mM KCl, 3 mM MgCl 2 , 5 mM dithiothreitol, 10 U of RNaseOut, and 50 U of SuperScript III (all Life Technologies; final concentrations) were added to a final volume of 10 µl. RT was performed at 25°C for 5 min, 50°C for 60 min, and 55°C for 15 min and terminated by heating to 70°C for 15 min.
Preamplification
After RT, cDNA was preamplified in 96-well plates (Roche Diagnostics) on a LightCycler 480 (Roche Diagnostics) with 4 µl template in a 40 µl of total reaction volume containing iQ Supermix (Bio-Rad Laboratories, Hercules, CA) and a primerpool, resulting in a final concentration of 0.040 µM of every primer (Sigma-Aldrich) later analyzed. The temperature profile was 95°C for 3 min followed by 14 cycles of amplification (95°C for 20 s, 55°C for 3 min, 72°C for 20 s) followed by 10 min at 72°C during which the run was interrupted and the plate was immediately placed on dry ice until completely frozen. After preamplification, the samples were slowly thawed, kept cold, and diluted 1:20 in 1X TE buffer (pH 8.0; Ambion, Life Technologies).
qPCR
A LightCycler 480 (Roche Diagnostics) was used for all qPCR measurements. To each reactionmix (8 µl) containing TATAA SYBR GrandMaster Mix (TATAA Biocenter, Gothenburg, Sweden) and 400 nM of each primer (Sigma-Aldrich), 2 µl of diluted preamplified cDNA was added to total reaction volume of 10 µl. All primers were designed with Primer3 (http://frodo.wi.mit.edu/ primer3/input.htm) or Primer-BLAST (NCBI) and Netprimer (Premier Biosoft International). The temperature profile was 95°C for 1 min followed by 50 cycles of amplification (95°C for 5 s, 60°C for 20 s, and 72°C for 20 s) and ending with a melt curve of 60-95°C. The formation of expected PCR products was confirmed by agarose gel electrophoresis. All samples were analyzed by melting curve analysis. Primer sequences are listed in Supplementary Table S1 .
Single-Cell qPCR Data Processing and Analysis
Data processing was performed as described (Stahlberg et al. 2013 ). In brief, false positive samples were eliminated based on melt curve analysis and gel electrophoresis. Gene expression data were converted into relative quantities, relative to quantification cycle (Cq) 37, which was set as cut off threshold. Gene expression data above Cq 37 and missing data were set to Cq 38 and all data were log 2 transformed, as the gene expression in the cell population showed a lognormal distribution. The data were not normalized to any reference genes. Heat maps and principal component analyses (PCA), were generated with GenEx software (MultiD, Gothenburg, Sweden) and each gene was autoscaled. The heat map analysis was conducted with Ward's algorithm and Euclidean distance measure. Samples negative for all genes were excluded from further analysis. The processed data set is provided as Supplementary Material online.
Immunohistochemical Analysis and Microglia Quantification
Four days after the lesion, mice were deeply anaesthetized and perfused with buffered paraformaldehyde. Immunohistochemistry was performed as described before (Wilhelmsson et al. 2012 ) using rabbit anti-AIF1 antibody (Wako Chemicals, Neuss, Germany) followed by donkey anti-rabbit antibody conjugated with Alexa 555 (Life Technologies, Paisly, UK) and DAPI to visualize cell nuclei. Cx3cr1-GFP-positive and AIF1-positive microglia were counted on 3 horizontal sections 360 µm apart in 3 non-overlapping areas of the hippocampus; 1) molecular layer of the dentate gyrus, 2) CA2/CA3, and 3) CA1 fields of stratum radiatum and stratum lacunosum moleculare, on images acquired by confocal microscopy and Image J software (rsbweb. nih.gov/ij/).
Primary Astrocyte and Microglia Cultures
Astrocyte enriched primary cultures and microglia enriched primary cultures were prepared in parallel as described previously (Hassan et al. 1991; Tamashiro et al. 2012; de Pablo et al. 2013; ) with minor modifications. Two male and 2 female Cx3cr1-GFP mice at postnatal day 2 were decapitated and brains were dissected under sterile conditions. Hippocampi were isolated for astrocyte cultures and forebrains were isolated for microglia cultures. The tissue were freed from meninges and incubated for 10 min in 0.25% trypsin in HBSS (both from Life Technologies) at 37°C. Trypsin was removed and the tissues were pooled and mechanically dissociated in DMEM (Sigma-Aldrich) supplemented with 10% FBS (HyClone, Thermo Fisher Scientific). For astrocyte cultures, the cell suspension was plated on 2 poly-D-lysine (PDL; Sigma-Aldrich) coated 75 cm 2 flasks. Cells were incubated in DMEM supplemented with 10% FBS, glutamine, penicillin, and streptomycin (growing media) in a 5% CO 2 humidified incubator. Every other day the cultures were shaken and the growing media replaced. After 7 days in culture, astrocytes were detached by 10 min incubation with TrypLE (Life Technologies), replated on PDL coated glass coverslips at a density of 32.000 cells/cm 2 , and maintained in growing media for 3 days before initiating the treatments. For microglia cultures, the forebrain cell suspension was plated on 4 PDL coated 75 cm 2 flasks. Cells were incubated in growing media in a 5% CO 2 humidified incubator. After 12 days in culture, loosely attached cells were detached by vigorously shaking the flasks, replated on PDL coated glass coverslips at a density of 22.000 cells/cm 2 , and maintained in growing media for 24 h before initiating the treatments. Treatments were performed in triplicate. Control cells were maintained for 48 h in growing media without FBS. LPS treatment 1 µg/ml for 48 h was applied in growing media without FBS. For oxygen and glucose deprivation (OGD), cells were incubated in 51 mM NaCl, 65 mM K-gluconate, 0.13 mM CaCl 2 , 1.5 mM MgCl 2 , and 10 mM HEPES pH 6.8 for 18 h in a humidified incubator set at 1% O 2 , 5% CO 2 , 94% N 2 at 37°C, followed by 24 h in growing media without FBS in regular culture conditions.
At the end of the treatment, cells were fixed in 4% paraformaldehyde in PBS for 20 min at room temperature. Cells were permeabilized for 20 min in PBS containing 0.5% TX100 and 5% FBS to block unspecific binding. GFAP was detected by incubation with rabbit-anti-GFAP antibodies (1:1000, Dako, Glostrup, Denmark) for 3 days at 4°C, followed by DAPI and donkey antirabbit-conjugated Alexa 555 antibodies (1:1000, Life Technologies) for 1.5 h at room temperature. Samples were washed 3 times in PBS between all incubations. Coverslips were mounted on glass slides using mowiol. For quantification, images were taken automatically from an equivalent area using the 20× objective for microglia cultures and 10× objective for astrocyte cultures. Cells from non-transgenic animals were used to set the threshold for GFP intensity, cells from GFAP-deficient animals were used to set the GFAP threshold. Volocity software (Perkin Elmer) was used to count the total number of cells; double-labeled cells and microglia cells were counted manually. Representative images were taken using the 40× objective according to the same selection criteria; brightness and contrast were adjusted a posteriori for publication.
Human Brain Samples
All experiments involving human post-mortem brain material were approved by the local ethical committee (ethical permit no. EPN 2013/474-31/2). Tissue Microarray (TMA) paraffinembedded block containing temporal cortex samples from 10 AD, 10 Lewy body dementia subjects, and 10 age-matched controls together with TMA block containing peri-necrotic (i.e., non-infarcted) cortical samples from 14 sub-acute ischemic stroke subjects with post-stroke survival of 4-7 days and 5 matched controls were constructed (Kampf et al. 2012; Adori et al. 2015) . AD and Lewy body dementia subjects had end stage disease (i.e., years after onset and diagnosis) with severe neocortical involvement, consistent with Braak & Braak tau stage 6 (out of 6) and "diffuse neocortical" Lewy body stage according to the current McKeith diagnostic criteria. Control tissues were from patients who died of non-CNS diseases, in accordance with the established case selection strategy in human tissue research. TMA slides were double-stained on a BOND-RX autostainer (Leica Microsystems, Wetzlar, Germany) with a combination of antibodies against S100β (HPA015768, rabbit polyclonal, Atlas Antibodies, Stockholm, Sweden) and AIF1/Iba1 (AB5076, goat polyclonal, Abcam, Cambridge, UK) or with a combination of antibodies against Tmem119 (HPA051870, characterized in Satoh et al. (2016) , rabbit polyclonal, Atlas Antibodies), Aldh1l1 (HPA039600, rabbit polyclonal, Atlas Antibodies), and GFAP (AB4674, chicken polyclonal, Abcam) using the tyramide signal amplification (TSA) method. Briefly, sections were deparaffinised, rehydrated, and treated for 20 min in a citrate-based pH 6.0 solution. Slides were incubated with the primary antibody for 4 h at room temperature, washed in PBS, blocked in TNB Buffer, and incubated for 90 min at room temperature with the secondary antibody. Sections were then washed again in PBS and incubated in TSA solution for 15 min, washed again and finally immersed for 10 min in 1% Sudan Black solution in 70% ethanol to quench autofluorescence, before mounting using DAPI-containing mounting medium (Invitrogen).
Fluorescence microscope images were acquired on a Vslide scanning microscope (MetaSystems, Alltlussheim, Germany) using 20× objectives and appropriate filter sets. Whole microscope slides were scanned at 2.5× and tissue was detected based on the DAPI signal. After generating a position map, all tissue-covered areas were scanned using 20× primary objective. Individual field of view images were stitched to generate a large 3-channel fluorescence image of the entire specimen with microscopic resolution. Images obtained with Vslide were analyzed using Metaviewer (MetaSystems). Cells positive for both Tmem119 and GFAP, and for AIF1 and S100β, respectively, were further investigated by a Zeiss LSM 700 inverted confocal microscope (Carl Zeiss, Stockholm Sweden) and orthogonal sections were made using Zen software (Carl Zeiss, Stockholm, Sweden). Validation of antibody affinity and specificity is presented in Supplementary Figure S1 .
Statistical Analysis
Univariate statistical analyses of the gene expression data were performed on log 2 transformed data with all negative data (missing data and data not passing initial Cq threshold) removed. IBM SPSS Statistics Version 20 was used for Spearman correlation calculations, Pearson chi-square tests, and one-way ANOVAs. Oneway ANOVAs were calculated with Dunnett's post hoc, comparing the log 2 expression of cells from uninjured control hippocampus with that of cells from injured or contralesional hippocampus.
One-way ANOVA followed by Tukey's post hoc analysis was used to analyze data on AIF1-positive and GFP-positive microglia numbers in uninjured, injured, and contralesional hippocampus. Two-tailed, non-paired t-test followed by Bonferroni's post hoc analysis was used to analyze the data from the cell culture experiments. Numbers are expressed as mean ± SEM and fold Δ are based on the mean gene expressions of the respective group prior to log 2 transformation. Differences were considered as statistically significant at P < 0.05.
Results
Injury Increases the Fraction of Cells Expressing Microglia-Specific Genes
To assess the cellular responses to injury, we used an indirect injury model in which entorhinal cortex lesion interrupts the axonal connections in the perforant path that innervates the outer molecular layer in the hippocampal dentate gyrus (for review see Deller et al. 2007) . Following tissue dissociation, the expression of selected genes (presented in Table 1 ) in individual cells was assessed without any prior selection or cell enrichment. The expression of Cx3cr1, Aif1, Cd68, Itgam (coding for CD11b), and Ccr2 in cells isolated from the hippocampus from uninjured (i.e., control mice), injured and contralesional hippocampus, and the correlation coefficient for their expression levels in individual cells, are summarized in Table 2 . These results show that Cx3cr1, Aif1, Cd68, and Itgam are co-expressed in almost all cells that are positive for any of these markers regardless of whether these cells were isolated from the control, injured or contralesional hippocampus (Fig. 1a) . Injury increased the proportion of cells co-expressing Cx3cr1 and Ccr2 (Fig. 1b) . PCA showed a distinct subpopulation of cells characterized by high relative expression of microglia/macrophage markers Cx3cr1, Aif1, Cd68 and Itgam, and another subpopulation defined by high relative expression of astrocyte markers Gfap, Slc1a2, Slc1a3, and Slc6a11. Cx3cr1, Aif1, Cd68, and Itgam together with C1qc formed a tight cluster, whereas Ccr2 was positioned outside this cluster (Fig. 1c,d) .
The expression levels of Aif1 were higher in cells isolated from the injured and contralesional hippocampus compared to cells isolated from the uninjured hippocampus (fold Δ 8.29, P < 0.001 and 7.59, P < 0.001, respectively). The expression levels of Itgam were higher in cells isolated from the injured compared to uninjured hippocampus (fold Δ 3.24, P < 0.001). In contrast, the expression levels of Cx3cr1 and Cd68 in individual cells did not change after injury (Table 3) .
Entorhinal cortex lesion leads to secondary neurodegeneration in the ipsilesional hippocampus (Fig 2a) . Immunohistochemical analysis of brain tissue sections of lesioned mice expressing GFP under the control of Cx3cr1 showed a clear increase both in AIF1 immunoreactivity and in GFP intensity in the denervated areas of injured hippocampus, while there was only a modest increase in the contralesional compared to the uninjured hippocampus (Fig. 2b,c) . Although the fraction of cells expressing Cx3cr1, Aif1, Cd68, and Itgam mRNA was higher in the injured and contralesional hippocampus compared to uninjured hippocampus, the density of cells visualized by antibodies against AIF1 or by Cx3xr1-GFP was higher only in the deafferented hippocampus (Fig. 2d) .
The Expression of Ccr2 Identifies 2 Subpopulations of Cx3cr1
+ Microglia/Macrophages with Otherwise
Similar Gene Expression Profiles
The proportion of Ccr2 positive cells was not changed after injury whereas the mean expression levels of Ccr2 mRNA were reduced in cells isolated from the injured and contralesional hippocampus compared to individual cells isolated from the uninjured hippocampus (fold Δ −1.54, P < 0.05, and −2.22, P < 0.001, respectively, Table 3 ). Regardless of injury, more than 50% of Cx3cr1 positive cells also expressed Ccr2 (Fig. 3a) . (Fig. 3a) , although the expression levels of Cx3cr1 mRNA in the Cx3cr1 + Ccr2 + cells were almost 2-fold higher compared to the Cx3cr1 + Ccr2 − cell population (P < 0.01). In PCA, the majority of Ccr2 + cells appeared outside the microglia/ macrophage cluster ( Fig. 3b in blue) , suggesting that the Ccr2-expressing cells comprise at least 2 distinct subpopulations.
Ccr2 mRNA Expression is not Limited to the Monocyte/ Macrophage Population
Regardless of injury, a large fraction of Ccr2 + cells co-expressed vimentin (Vim) mRNA and over 24% of those cells also expressed Gfap mRNA (Fig. 3c ). All cells positive for endothelial cell marker von Willebrand factor (Vwf) expressed also Vim mRNA. In the uninjured and contralateral hippocampus, at least 50% of Vwf + cells expressed Ccr2 mRNA, the fraction of Vwf
was lower in the cell population isolated from the injured hippocampus (Fig. 3d) . Jointly, these results suggest that Ccr2 mRNA expression is not limited to the monocyte/macrophage population and can also be found in astrocytes and endothelial cells. Based on PCA, the Vim
+
Ccr2
+
Vwf
+ cells appear to constitute a homogenous population (all found in a single cell cluster) as compared to cells positive for Vim, Ccr2, and Gfap mRNA and cells positive for Vim and Ccr2 mRNA, which show a much broader distribution pattern (Fig. 3e) .
Some Cells Co-Express Microglia and Astrocyte Markers After Injury
The expression of Cx3cr1, Glul (coding for glutamine synthetase), Slc1a3 (coding for GLAST), Slc1a2 (coding for GLT-1), Gfap, and Ccr2 in individual cells isolated from the uninjured, injured, and contralesional hippocampus as well as the correlation coefficient for their expression levels are summarized in Supplementary Tables S2-S4 . These data show that whereas the expression of Cx3cr1 and Gfap define 2 non-overlapping populations of cells in the uninjured hippocampus, injury leads to the co-expression of these markers in some cells in the injured and contralesional hippocampus (Fig. 4a) . Almost 80% of Cx3cr1 + microglia/macrophages expressed Slc1a3 in the uninjured hippocampus and 44-75% of microglia/macrophages expressed Slc1a3 after injury. The majority of cells expressing Slc1a3 were negative for Cx3cr1 in the uninjured hippocampus but the fraction of cells co-expressing Slc1a3 and Cx3cr1 increased after injury from 12% in control to 27% (P < 0.05) and 28% (P < 0.01) in injured and contralesional hippocampus, respectively. Thus, Slc1a3 is expressed by microglia/macrophages and Gfap positive astrocytes isolated from the uninjured, injured as well as contralesional hippocampus. In the heat maps with cluster dendrograms based on the expression profiles, cells co-expressing Cx3cr1 and Gfap are found solely in the microglia cluster ( Fig. 4b-d) . The appearance in the deafferented hippocampus of cells coexpressing genes canonically regarded as markers of astrocytes and microglia, respectively, triggered us to search the published datasets of microglia transcriptomes available in the online platform Glia Open Access Database (http://bioinf. nl:8080/GOAD2/databaseSelectServlet) (Holtman et al. 2015) for upregulation of Gfap in microglia in an injury or disease context. Indeed, transcriptome data suggested increased expression of Gfap in 2 datasets comparing microglia isolated from 2 experimental models of AD with microglia from control mice (fold Δ 4.4, adjusted P value 2.5 × 10 −8 (Wang et al. 2015) , and fold Δ 1.3, adjusted P value 4.5 × 10 −4 (Orre et al. 2014) ).
Exposure to LPS, an In Vitro Injury Model, Increases the Fraction of Cultured Cells Co-Expressing CX3CR1 and GFAP
To investigate whether CX3CR1 and GFAP co-expression can be detected in cultured cells and to avoid a possible cross-reactivity of antibodies used for marker visualization, we prepared primary astrocyte and microglia cultures from Cx3cr1-GFP mice. We found that in both cell cultures, less than 5% of GFP expressing cells were positive for GFAP under control conditions (serumfree). Addition of LPS but not serum or oxygen-glucose deprivation led to a dramatic increase in the fraction of GFP + cells that co-expressed GFAP in astrocyte and microglial cell cultures alike (Fig. 5a,b) . As both primary cell cultures contain microglia and astrocytes (microglia constituted 0.8 ± 0.30% of cells in the astrocyte cultures; astrocytes constituted 13.5 ± 1.50% of cells in the microglia cultures) and microglia are prone to cell fusion (Cusulin et al. 2012) , we addressed the possibility of fusion between the GFP + microglia and GFAP + astrocytes. In astrocyte and microglia cultures treated with LPS, we found that 56 ± 0.2% and 5.6 ± 1.1%, respectively, of the GFP + GFAP + cells contained 2 nuclei (Fig. 5c,d ). These findings show that in primary cell cultures that contain astrocytes and microglia, LPS increases the fraction of cells expressing both microglial and astrocyte markers and at least some of these dual identity cells are the result of cell fusion.
Cells Co-Expressing Microglia and Astrocyte Markers are Present in Diseased Human Brain
Having established that cells co-express markers of microglia and astrocytes in injured mouse brains and in LPS-induced microglial cultures, we wanted to determine whether such cells are present in human brain. We used tissue microarrays containing temporal cortex samples from AD (10 subjects), Lewy body dementia (10 subjects), and 10 control subjects as well as tissue microarray containing cortical samples from 14 ischemic stroke subjects on which microglia/monocytes and astrocytes were visualized by 2 immunostaining combinations. When astrocyte markers GFAP and Aldh1l1 (Cahoy et al. 2008) were combined with microglia marker Tmem119 (Bennett et al. 2016; Satoh et al. 2016) , we found several cells co-expressing microglia and astrocyte markers in samples from 5 subjects affected by stroke (Fig. 6 ) and 1 cell in one of the control subjects. When co-staining with antibodies against microglia marker AIF1 and astrocyte marker S100β, we detected cells that expressed both markers in samples from one subject affected by AD, one subject affected by Lewy body dementia, as well as in grey matter samples from 2 subjects affected by ischemic stroke. Many of these cells showed morphological features of astrocytes (Fig. 6) . These results show that cells co-expressing microglia and astrocyte markers are present in the diseased human brain.
C1qc is Expressed by Microglia/Macrophages as well as Astrocytes
In the uninjured hippocampus, about 25% of the C1qc positive cells expressed the microglia/macrophage markers Aif1, Cd68, Cx3cr1, and Itgam; 34% of the C1qc positive cells were positive inal cortex, microglia show enhanced AIF1 immunoreactivity and increased Cx3cr1-GFP intensity in the deafferented areas of the hippocampus on the injured side compared to the contralesional side and to uninjured mice. The hippocampal formation is delineated with a white line and the lesion is indicated with asterisks in white. (b and c) Microglia show increased Cx3cr1-GFP intensity and AIF1 immunoreactivity in the molecular layer of the dentate gyrus (mcl) and stratum lacunosum moleculare (slm) on the injured side, the main projection areas of the deafferented neurons, while microglia response on the contralesional side is subtle. (d) Density (±SEM) of microglia positive for AIF1 and Cx3cr1-GFP within 3 areas of the injured, contralesional, and uninjured (control) hippocampus. Scale bars, 250 µm; **P < 0.01; ***P < 0.001; ****P < 0.0001; DG mcl, molecular cell layer of the dentate gyrus. for Gfap. C1qc was expressed in 52% of Vim positive cells. The expression levels of C1qc and Cx3cr1 as well as Cd68 were positively correlated (Supplementary Table S2 ). In the injured hippocampus, around 75% of the C1qc positive cells were positive for Aif1, Cd68, Cx3cr1, and Itgam; 25% were positive for Gfap. The expression levels of C1qc were positively correlated with those of Aif1, Cd68, Cx3cr1, Itgam as well as Glul whereas there was a negative correlation between the expression levels of C1qc and Vim (Supplementary Table S3 ). In the contralesional hippocampus, over 50% of the C1qc positive cells were positive for Aif1, Cd68, and Cx3cr1, whereas only 14% were positive for Gfap. The expression levels of C1qc were positively correlated with the expression of Aif1, Cd68, and Itgam whereas they were negatively correlated with the expression of Slc1a3 and Vim (Supplementary Table S4 ). The proportion of C1qc positive cells increased from 55% in uninjured control hippocampus to 80% in injured hippocampus and 72% in contralesional hippocampus (P < 0.001 and P < 0.05, respectively). The expression levels of C1qc were higher in cells isolated from the injured and contralesional hippocampus The fraction of GFAP + GFP + within the GFP + population was counted in cultures maintained for 48 h in serum-free media (C), in media with 10% serum (FBS), treated with 1µg/ml LPS in serum-free media for 48 h (LPS), or deprived of oxygen and glucose for 18 h followed by incubation in regular culture conditions without serum for 24 h (OGD). (c and d) Some GFAP + GFP + cells in LPS-treated astrocyte (c) and microglia (d) cultures contained 2 nuclei. **P < 0.01, ***P < 0.001. Scale bars a-d, 25 µm. and astrocyte markers GFAP and Aldh1l1 in orthogonal sections of brain from subjects affected by ischemic stroke. Arrowheads, cell co-expressing Tmem119, GFAP, and Aldh1l. (c-e) Cells co-expressing AIF1 and astrocyte marker S100β in orthogonal sections of brain from subjects affected by Lewy body dementia (c), ischemic stroke (d), and AD (e) immunostained with antibodies against AIF1 and S100β. Arrowheads, cell double positive for AIF1 and S100β. Dapi visualizes cell nuclei. Scale bars a-e, 10 µm.
compared to cells isolated from the uninjured hippocampus (fold Δ 15.56, P < 0.001, and 2.89, P < 0.05, respectively, Table 3 ). Jointly, these results show that regardless of condition, C1qc is expressed by microglia as well as astrocytes and the expression levels of C1qc increase after injury.
Microglial Cells Express High Levels of C1qc
Based on the expression levels of C1qc, we identified 2 distinct subpopulations of cells. The high C1qc-expressing cells in the control hippocampus expressed Aif1, Cd68, Cx3cr1, and Itgam; these cells were negative for Gfap and showed very low expression levels of Slc1a3, Slc1a2, and Vim. In the injured and contralesional hippocampus, the majority of high C1qc-expressing cells expressed Aif1, Cd68, Cx3cr1, and Itgam; some of these cells expressed also relatively high levels of Gfap, Slc1a3, Slc1a2, and Vim. In contrast, many of the low C1qc-expressing cells in the uninjured hippocampus expressed relatively high levels of Gfap, Slc1a3, and Slc1a2. After injury, the low C1qc-expressing cells expressed high levels of Gfap, Slc1a2, and Vim or high levels of Vwf (Fig. 7a-c) .
The heat maps with cluster dendrograms based on the expression profiles add further support to the conclusion that C1qc expression is co-regulated with the expression of microglia/ macrophage markers Aif1, Cd68, Cx3cr1, and Itgam regardless of condition ( Fig. 4b-d) . Jointly, these results suggest that the high C1qc-expressing cells are microglia/macrophages whereas the low C1qc-expressing cells constitute an astrocyte and/or Vwf positive endothelial cell population.
In Response to Injury, Microglial Cells Express Vimentin
In the uninjured hippocampus, around 15% of the cells expressing Aif1, Cd68, Cx3cr1, and Itgam were positive for Vim. The expression of Vim and the microglia/macrophage markers did not correlate. In the injured and contralesional hippocampus, over 85% of the cells expressing Aif1, Cd68, Cx3cr1, and Itgam were positive for Vim. Thus the majority of microglia/ macrophages expressed Vim after injury.
The proportion of Vim positive cells was increased in the injured and contralesional compared to uninjured hippocampus (P < 0.01 and P < 0.001, respectively). The expression levels of Vim were significantly higher in cells isolated from the injured and contralesional hippocampus compared to cells isolated from the uninjured hippocampus (fold Δ 1.38, P < 0.05, and 3.23, P < 0.001, respectively). The scatter plots showing the expression levels of Vim against those of the microglia/macrophage marker Cx3cr1 showed that in the uninjured hippocampus, the majority of Vimexpressing cells did not co-express Cx3cr1, whereas a population of cells expressing moderate to high levels of Vim together with high levels of Cx3cr1 was abundant both in the injured and the contralesional hippocampus (Fig. 7d) . Three subpopulations of cells were identified from the uninjured hippocampus based on the expression levels of Vim and C1qc: Vim (Fig. 7e) . These results suggest that microglia/macrophages do not express Vim under basal conditions, but can do so in response to injury.
Discussion
The major finding from our study is that in the injured brain as well as in brain affected by stroke or chronic neurodegeneration, some cells co-express genes that are traditionally regarded as markers specific for very distinct cell populations with a different embryologic origin. First, we showed that Gfap is co-expressed with Cx3cr1, Aif1, CD68, and Itgam in some cells in the injured and contralesional but not control hippocampus. This is supported by increased Gfap expression in transcriptomes obtained from microglia populations in AD disease models compared to control microglia (Orre et al. 2014; Wang et al. 2015) . Slc1a3 and Glul on the other hand, were expressed by both microglia and astrocytes in the unchallenged hippocampus as well as after injury, which is in line with previous reports (Beschorner et al. 2007a (Beschorner et al. , 2007b and with global microglia transcriptome data (Zhang et al. 2014; Bennett et al. 2016) (available online at http://web.stanford.edu/group/barres_lab/ brainseq2/brainseq2.html). Likewise, recent report demonstrates that although the development of microglia proceeds through 3 distinct temporal stages, each defined by a characteristic gene expression profile, Slc1a3 and Glul, but not Slc1a2, are expressed at all developmental stages from myeloid progenitors in the yolk sac to microglia in the adult brain and spinal cord. While the authors used also single-cell gene expression profiling to confirm that the temporal dynamics of microglia development are the most dominant discriminative feature, they did not perform expression profiling of microglia after injury or other challenge (Matcovitch-Natan et al. 2016) . The absence of Gfap expression in their global or single-cell microglia profiles is in line with our findings from uninjured mice. Second, using immunostaining with antibodies against GFAP and fluorescence microscopy, we demonstrated that cells co-expressing GFP together with GFAP can be identified in primary cell cultures prepared from the brains of Cx3cr1-GFP mice and the fraction of such double positive cells increases after exposure to LPS. Our results indicate that at least some of the dual identity cells in our cultures arise through cell fusion, which is in line with the previously reported fusogenic role of activated microglia (Cusulin et al. 2012) .
Third, and most importantly, we showed using 2 sets of antibody combinations that cells co-expressing microglia and astrocyte markers are also present, although in low numbers, in the human brain from ischemic stroke and 2 chronic neurodegenerative conditions, namely AD and Levy body dementia. As the control brain specimens were selected based on the absence of relevant neurological diagnosis, it is possible that an unidentified neuropathology was the underlying cause for the presence of the single cell co-expressing astrocyte and microglia markers observed in one of the 10 control brain specimens. Thus, the appearance of cells with dual identity seems to be a widespread phenomenon associated with CNS pathology. In support of this notion, Trias et al. described in a rat model of amyotrophic lateral sclerosis a population of neurotoxic atypical spinal cord astrocytes expressing both GFAP and AIF1 antigens and provided evidence for a subpopulation of proliferating microglia undergoing phenotypic transition into astrocyte-like cells as a mechanism underlying the appearance of such cells (Trias et al. 2013) . Heterotypic fusion of endogenous cells in the brain, hypothesized to serve the purpose of cell rescue during neurodegeneration, has been described for cerebellar Purkinje neurons and bone marrow-derived myeloid cells (reviewed in Kemp et al. 2014) . Notably, as over 50% of the Cx3cr1
+
Gfap
+ cells expressed also Ccr2 mRNA, it is possible that at least some of these cells isolated from the injured mouse brain in our study did arise through the fusion of astrocytes and blood-born monocytes. Alternatively, the Ccr2-expressing astrocytes may be more prone to fuse with microglia than astrocytes negative for Ccr2. Future studies will determine the specific mechanisms underlying the generation of the cells with both microglia and astrocyte characteristics in the diseased human brain, the temporal pattern of their appearance as well as elucidate their functions. We found that in individual cells isolated from mouse hippocampus, all 4 of the microglia/macrophage markers assessed, i.e., Cx3cr1, Aif1, Itgam, and Cd68, were co-expressed. The mRNA levels of Cx3cr1 and Cd68 in individual cells did not change in response to injury, while Aif1 and Itgam were upregulated in cells isolated from the injured and Aif1 also in the contralesional hippocampus. The expression levels of Aif1 and Itgam did not correlate in the uninjured hippocampus but showed a positive correlation after injury. Similarly, there was no correlation between expression levels of Cx3cr1 and Itgam or Aif1 in the uninjured hippocampus but there was a positive correlation between the mRNA levels of these genes after injury. Jointly, these results show that Cx3cr1, Aif1, Itgam, and Cd68 are equally reliable markers of microglia/macrophages in the unchallenged as well as deafferented hippocampus.
Our findings of the increased proportion of Cx3cr1, Aif1, Itgam, and Cd68 positive cells in the injured and contralesional compared to uninjured hippocampus and the higher expression levels of Aif1 in cells isolated after injury imply that also microglia in the contralesional hippocampus respond to deafferentation and this response is similar to that in the injured hippocampus. This is in line with a previous report on contralesional microglia response after entorhinal cortex lesion (Hailer et al. 1999 ) and is conceivably due to the fact that in mice up to 20% of the projections from entorhinal cortex to the hippocampal CA1 and subiculum are crossed (van Groen et al. 2003) .
We observed that over 50% of Cx3cr1 positive cells expressed Ccr2. The fraction of cells expressing both markers increased after injury but there was no correlation between the expression of these 2 genes. While the fraction of Cx3cr1 + cells increased in response to injury, the relative size of Ccr2 positive cell population (including also Cx3cr1 − non-myeloid cells) did not change.
Regardless of Ccr2 expression, the expression levels of Cx3cr1 were surprisingly stable. Only one cell could be classified as Cx3cr1 low Ccr2 + and thereby considered to be a blood-born monocyte (Geissmann et al. 2003) . Thus, using the expression of Ccr2, we identified 2 subpopulations of Cx3cr1-expressing cells, namely Ccr2 − and Ccr2 + , which differed in the expression levels of Cx3cr1, however the expression profiles of all other genes were similar. Using knock-in reporter mice in which the expression of fluorescent proteins was driven by the Cx3cr1 and Ccr2 promoters, occasional Cx3cr1
+
Ccr2
+ cells (presumably bonemarrowderived monocytes) in the perivascular space were reported (Saederup et al. 2010) . These Cx3cr1 + Ccr2 + cells were more abundant in mice with experimental autoimmune encephalomyelitis (Saederup et al. 2010) . Further, adult microglia in these reporter mice did not show significant Ccr2 expression in an unchallenged brain or upon inflammation (Mizutani et al. 2012) . It is therefore possible that the Cx3cr1
+
Ccr2
+ cells detected in our study represent the blood-derived monocytes or perivascular blood-born monocyte population in which Ccr2 is rapidly downregulated upon differentiation into tissue macrophages (Wong et al. 1997) . Thus, the Ccr2 mRNA may not be translated, at least in some of these cells. Our findings of increased fraction of Cx3cr1
+
Ccr2
+ cells among cells isolated from the injured as well as contralesional hippocampus support the notion that deafferentation leads to the recruitment of blood monocytes to the hippocampus (Babcock et al. 2003; Bechmann et al. 2005; Wirenfeldt et al. 2005) . Our findings of co-expression of Ccr2 mRNA with Gfap (astrocyte marker) and Vwf (marker of endothelial cells) support the conclusion that Ccr2 expression is not limited to the monocyte population and that the majority of Cx3cr1 -
+ cells appear to be astrocytes or endothelial cells. These results are in agreement with reports demonstrating functional expression of CCR2 on astrocytes (Quinones et al. 2008; Kawaguchi-Niida et al. 2013 ) and endothelial cells (Weber et al. 1999) . As the fraction of cells coexpressing Ccr2 and astrocyte markers did not change after injury, the expression of Ccr2 does not seem to be limited to reactive astrocytes as previously suggested (Kawaguchi-Niida et al. 2013) . In contrast to results obtained from in vitro studies (Persson et al. 2005 (Persson et al. , 2009 Morioka et al. 2008) , we detected only very few microglial cells expressing Slc1a2 and their number did not increase after injury. As a transient upregulation of both Slc1a3 and Slc1a2 was detected in microglia/macrophage cells after ischemia in rats (Arranz et al. 2010) , it is possible that more potent stimuli, such as ischemia or other more severe injury, is needed for microglial upregulation of Slc1a2 expression. Based on evidence for region-specific differences in microglia density, phenotype, and responsiveness (de Haas et al. 2008) , it is also possible, that the upregulation of Slc1a2 by microglia is regionspecific.
We found that microglia isolated from the uninjured as well as injured and contralesional hippocampus expressed C1qc and the expression levels of C1cq were positively correlated with those of Cd68. In the cells isolated from the injured hippocampus, the expression levels of C1qc were positively correlated also with those of Cx3cr1 and Aif1. These findings are in line with previous reports demonstrating high C1q expression in microglia and the relative increase in numbers of these cells after injury (Schafer et al. 2000; Lynch et al. 2004; Depboylu et al. 2011a Depboylu et al. , 2011b . PCA showed that the low C1qc-expressing cells clustered together with astrocytes or endothelial cells. Thus, based on the expression levels of C1qc, we identified 2 subpopulations of cells, namely high C1qc-expressing microglia and low C1qc-expressing astrocytes and/or endothelial cells. While cortical astrocytes were reported to upregulate C1qc expression in the context of AD (Kamphuis et al. 2015) , the high C1qc-expressing cells in our study are predominantly microglia. Whether the main determinant of this difference in astrocyte response to Alzheimer type pathology and deafferentation is regional specificity, age or the type of injury remains to be elucidated.
We also found that C1qc is expressed in a large fraction of Vim positive cells, this fraction increases in both injured and contralesional hippocampus. After injury, the expression levels of C1qc and Vim show a negative correlation. Based on the expression levels of Vim and C1qc, we identified 3 subpopulations of cells isolated from the uninjured hippocampus. An additional population of cells, namely those with very high C1qc expression and moderate expression of Vim appeared among cells isolated from the injured and contralesional hippocampus. As the high C1qc-expressing cells tend to cluster with microglia in PCA, and Vim-expressing cells that co-express microglial markers appear mainly after injury, we hypothesize that this fourth population of C1qc and Vim co-expressing cells constitutes activated microglia. This conclusion is in line with a recent report showing that vimentin plays a role in controlling microglia activation (Jiang et al. 2012 ).
Microglia were shown to proliferate in the ipsilateral as well as contralesional hippocampus after entorhinal cortex lesion with a peak in microglia counts 3 days after lesion (Hailer et al. 1999) . Our results show that the fraction of cells expressing Cx3cr1, Aif1, Itgam, and Cd68 mRNA was higher in the injured and contralesional compared to uninjured hippocampus. However, higher numbers of cells stained with antibody against AIF1 or expressing Cx3cr1-GFP were detected mainly in the molecular cell layer of the dentate gyrus on the injured side, the main projection area of the lesioned neurons, but not in the contralesional hippocampus. It is therefore possible, that the isolation procedure used in our study to some degree favors activated microglia over other cells types.
In summary, we have shown that the expression levels of C1qc identify 2 subpopulations of glial cells, namely high C1qc-expressing microglia and low C1qc-expressing astrocytes or endothelial cells. A population of cells co-express Cx3cr1 and Ccr2 mRNA regardless of injury and deafferentation induces expression of Gfap and Vim mRNA in cells expressing microglial markers, both in the injured and contralesional hippocampus. Most importantly, our results indicate that in mouse as well as human brain injury and chronic neurodegeneration lead to the appearance of cells that share molecular characteristics of microglia and astrocytes.
